Abstract
Helicobacter pylori is a spiral-shaped, flagellated, microaerophilic Gram-negative bacillus which colonizes the gastric mucosa of more than 50% of human population. The chronic infection generates a state of inflammation, which however is asymptomatic in the majority of the subjects. Nevertheless, in a subset of the H. pylori-infected population, the gastric inflammation may evolve toward chronic gastritis, peptic ulcer, gastric mucosa-associated lymphoid tissue (MALT) lymphoma, and gastric cancer. In brief, the stages of the H. pylori colonization are the following: crossing of the gastric mucus layer, adhesion to the gastric epithelium, and then obtaining nutrients while avoiding to be defeated by the host immune response. For some H. pylori colonization/virulence factors a specific role has been suggested in the development of the inflammation and in the impact on the host immune system. On the other hand, some hosts factors have been found relevant in originating chronic gastric inflammation and the subsequent pathological outcome in the presence of H. pylori infection. In other words, both bacterial action and host response contribute to the pathogenesis. The host-pathogen coadaptation resulted in a H. pylori colonization that in most of the cases might remain harmless; however, the concomitance of particular genotypes of both pathogen and host may concur to the development of severe pathology. Although a large body of clinical and experimental observations have been provided since the discovery of H. pylori, a further knowledge of the mechanisms of host-pathogen interaction and of those that lead to achieve protective immunity against this pathogen is still necessary to guide and make efficacious the fight against H. pylori.
Keywords: Helicobacter pylori, colonization, virulence, inflammation, gastric disease, gastric cancer
Current Pharmaceutical Design
Title: Helicobacter Pylori and Inflammation
Volume: 16 Issue: 38
Author(s): Paolo Ruggiero
Affiliation:
Keywords: Helicobacter pylori, colonization, virulence, inflammation, gastric disease, gastric cancer
Abstract: Helicobacter pylori is a spiral-shaped, flagellated, microaerophilic Gram-negative bacillus which colonizes the gastric mucosa of more than 50% of human population. The chronic infection generates a state of inflammation, which however is asymptomatic in the majority of the subjects. Nevertheless, in a subset of the H. pylori-infected population, the gastric inflammation may evolve toward chronic gastritis, peptic ulcer, gastric mucosa-associated lymphoid tissue (MALT) lymphoma, and gastric cancer. In brief, the stages of the H. pylori colonization are the following: crossing of the gastric mucus layer, adhesion to the gastric epithelium, and then obtaining nutrients while avoiding to be defeated by the host immune response. For some H. pylori colonization/virulence factors a specific role has been suggested in the development of the inflammation and in the impact on the host immune system. On the other hand, some hosts factors have been found relevant in originating chronic gastric inflammation and the subsequent pathological outcome in the presence of H. pylori infection. In other words, both bacterial action and host response contribute to the pathogenesis. The host-pathogen coadaptation resulted in a H. pylori colonization that in most of the cases might remain harmless; however, the concomitance of particular genotypes of both pathogen and host may concur to the development of severe pathology. Although a large body of clinical and experimental observations have been provided since the discovery of H. pylori, a further knowledge of the mechanisms of host-pathogen interaction and of those that lead to achieve protective immunity against this pathogen is still necessary to guide and make efficacious the fight against H. pylori.
Export Options
About this article
Cite this article as:
Ruggiero Paolo, Helicobacter Pylori and Inflammation, Current Pharmaceutical Design 2010; 16 (38) . https://dx.doi.org/10.2174/138161210794519075
DOI https://dx.doi.org/10.2174/138161210794519075 |
Print ISSN 1381-6128 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-4286 |
Call for Papers in Thematic Issues
"Tuberculosis Prevention, Diagnosis and Drug Discovery"
The Nobel Prize-winning discoveries of Mycobacterium tuberculosis and streptomycin have enabled an appropriate diagnosis and an effective treatment of tuberculosis (TB). Since then, many newer diagnosis methods and drugs have been saving millions of lives. Despite advances in the past, TB is still a leading cause of infectious disease mortality ...read more
Current Pharmaceutical challenges in the treatment and diagnosis of neurological dysfunctions
Neurological dysfunctions (MND, ALS, MS, PD, AD, HD, ALS, Autism, OCD etc..) present significant challenges in both diagnosis and treatment, often necessitating innovative approaches and therapeutic interventions. This thematic issue aims to explore the current pharmaceutical landscape surrounding neurological disorders, shedding light on the challenges faced by researchers, clinicians, and ...read more
Emerging and re-emerging diseases
Faced with a possible endemic situation of COVID-19, the world has experienced two important phenomena, the emergence of new infectious diseases and/or the resurgence of previously eradicated infectious diseases. Furthermore, the geographic distribution of such diseases has also undergone changes. This context, in turn, may have a strong relationship with ...read more
Melanoma and Non-Melanoma Skin Cancer Treatment: Standard of Care and Recent Advances
In this thematic issue, we aim to provide a standard of care of the diagnosis and treatment of melanoma and non-melanoma skin cancer. The editor will invite authors from different countries who will write review articles of melanoma and non-melanoma skin cancers. The Diagnosis, Staging, Surgical Treatment, Non-Surgical Treatment all ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Dendritic Cells in Colorectal Cancer and a Potential for their Use in Therapeutic Approaches
Current Pharmaceutical Design Metabolic Effects of Bile Acids in the Gut in Health and Disease
Current Medicinal Chemistry The Prognostic and Predictive Value of microRNAs in Patients with H. pylori-positive Gastric Cancer
Current Pharmaceutical Design The Role of E-cadherin in Helicobacter pylori-Related Gastric Diseases
Current Drug Metabolism Nanomedicine: A New Frontier in Cancer Therapeutics
Current Drug Delivery Carbohydrate Microarray Technology for Functional Glycomics
Current Chemical Biology New Approach to Cancer Therapy: The Application of Signal Transduction to Anti-Cancer Drug
Current Medicinal Chemistry - Anti-Cancer Agents Marine Drugs: A Hidden Wealth and a New Epoch for Cancer Management
Current Drug Metabolism QSAR, Docking and Molecular Fragment Replacement Study based on a Conformation- Independent Approach on Trifluorophenyl β-aminoamide derivatives as DPP IV Inhibitors
Current Enzyme Inhibition Transcriptional Analysis of JAK/STAT Signaling in Glioblastoma Multiforme
Current Pharmacogenomics and Personalized Medicine Introduction: MMPs, ADAMs/ADAMTSs Research Products to Achieve Big Dream
Anti-Cancer Agents in Medicinal Chemistry Beta-Caryophyllene Suppresses Ovarian Cancer Proliferation by Inducing Cell Cycle Arrest and Apoptosis
Anti-Cancer Agents in Medicinal Chemistry GRP78 Influences Chemoresistance and Prognosis in Cancer
Current Drug Targets Rare Long-Term Complications Following Pancreaticoduodenectomy: Biliary and Pancreatic Lithiasis
Current Signal Transduction Therapy Resveratrol and Clinical Trials: The Crossroad from In Vitro Studies to Human Evidence
Current Pharmaceutical Design Investigating ABCB1-Mediated Drug-Drug Interactions: Considerations for In vitro and In vivo Assay Design
Current Drug Metabolism Homology Modeling in Drug Discovery-an Update on the Last Decade
Letters in Drug Design & Discovery Molecular Mechanisms of Epigenetic Regulators as Activatable Targets in Cancer Theranostics
Current Medicinal Chemistry Cyclin-Dependent Kinase Inhibition by Flavoalkaloids
Mini-Reviews in Medicinal Chemistry Cinnamic Acid Derivatives as Anticancer Agents-A Review
Current Medicinal Chemistry